Kylsans Drugs And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 0.36 M
- Company Age 36 Year, 3 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -78.41%
- Profit Growth 198.53%
- Ebitda 118.86%
- Net Worth 0.12%
- Total Assets -1.90%
About Kylsans Drugs And Chemicals
Kylsans Drugs And Chemicals Private Ltd. (KDACPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 February 1989 and has a history of 36 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 0.36 M, as per Ministry of Corporate Affairs (MCA) records.
Satinder Jain and Vibhor Jain serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1989PTC034968
-
Company No.
034968
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Feb 1989
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Kylsans Drugs And Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satinder Jain
|
Director | 08-Feb-1989 | Current |
|
Vibhor Jain
|
Director | 15-Nov-2008 | Current |
Financial Performance of Kylsans Drugs And Chemicals.
Kylsans Drugs And Chemicals Private Ltd., for the financial year ended 2020, experienced significant reduction in revenue, with a 78.41% decrease. The company also saw a substantial improvement in profitability, with a 198.53% increase in profit. The company's net worth moved up by a moderate rise of 0.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kylsans Drugs And Chemicals?
In 2018, Kylsans Drugs And Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Elizence Lifecare LimitedSatinder Jain and Vibhor Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kylsans Drugs And Chemicals?
Unlock and access historical data on people associated with Kylsans Drugs And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kylsans Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kylsans Drugs And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
